Open-Label Study of Hemin for Acute Porphyria: Clinical Practice Implications

American Journal of Medicine

Volumn 119, Issue 9, 2006, Pages

  Anderson, Karl E ^a,b   Collins, Stephen ^c  

^a Department of Preventive Medicine and Community Health ^*  (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c LUNDBECK RESEARCH USA   (United States)

Author keywords

Acute porphyria; Adverse events; Hemin prophylaxis; Hemin treatment

Indexed keywords

HEMATIN; HEMIN;

ACUTE INTERMITTENT PORPHYRIA; ADULT; ARTICLE; BACTEREMIA; CATHETER COMPLICATION; CELLULITIS; CLINICAL PRACTICE; CONTROLLED STUDY; CONVULSION; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG MANUFACTURE; DRUG SAFETY; FEMALE; FEVER; HEADACHE; HUMAN; INJECTION SITE PHLEBITIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN; PHARYNGITIS; PHLEBITIS; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; UNITED STATES; VOMITING;

ADULT; FEMALE; HEMIN; HUMANS; MALE; MIDDLE AGED; PORPHYRIA, ACUTE INTERMITTENT;

EID: 33747890565     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.05.026     Document Type: Article

References (29)

1. th edition (2001), McGraw Hill, New York, NY 2991-3062
2. Anderson K.E., Bloomer J.R., Bonkovsky H.L., et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med 142 (2005) 439-450
3. Elder G.H., Hift R.J., and Meissner P.N. The acute porphyrias. Lancet 349 (1997) 1613-1617
4. Mustajoki P., and Nordmann Y. Early administration of heme arginate for acute porphyric attacks. Arch Intern Med 153 (1993) 2004-2008
5. Thadani H., Deacon A., and Peters T. Diagnosis and management of porphyria. BMJ 320 (2000) 1647-1651
6. Anderson K.E. Approaches to treatment and prevention of human porphyrias. In: Kadish K., Smith K., and Guilard R. (Eds). The Porphyrin Handbook, Part II, Vol. 14, Medical Aspects of Porphyrins (2003), Elsevier Science, Amsterdam 247-283
7. Bonkowsky H.L., Tschudy D.P., Collins A., et al. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Proc Natl Acad Sci U S A 68 (1971) 2725-2729
8. Watson C.J., Pierach C.A., Bossenmaier I., and Cardinal R. Use of hematin in the acute attack of the "inducible" hepatic prophyrias. Adv Intern Med 23 (1978) 265-286
9. Lamon J.M., Frykholm B.C., Hess R.A., and Tschudy D.P. Hematin therapy for acute porphyria. Medicine (Baltimore) 58 (1979) 252-269
10. Dhar G.J., Bossenmaier I., Petryka Z.J., Cardinal R., and Watson C.J. Effects of hematin in hepatic porphyria. Further studies. Ann Intern Med 83 (1975) 20-30
11. European Porphyria Initiative Steering Committee (Badminton M, Deybach J-C, Elder G, et al.). Information for physicians: The porphyrics. Available as www.porphyria-europe.com. Accessed July 19, 2006.
12. Anderson K.E. The porphyrias. In: Goldman L., and Ausiello D. (Eds). Cecil Textbook of Medicine (2004), W. B. Saunders Co, Philadelphia, PA 1292-1300
13. Herrick A.L., McColl K.E., Moore M.R., Cook A., and Goldberg A. Controlled trial of haem arginate in acute hepatic porphyria. Lancet 1 (1989) 1295-1297
14. McColl K.E., Moore M.R., Thompson G.G., and Goldberg A. Treatment with haematin in acute hepatic porphyria. Q J Med 50 (1981) 161-174
15. Mustajoki P., Tenhunen R., Tokola O., and Gothoni G. Haem arginate in the treatment of acute hepatic porphyrias. Br Med J (Clin Res Ed) 293 (1986) 538-539
16. Wilson J, de Rooij F. Management and treatment of the porphyrias. In: Kadish KM, Smith KM, Guilard R, eds. The Porphyrin Handbook, Part II. Vol. 14, Medical Aspects of Porphyrins. Amsterdam, Elsevier Science.
17. Lamon J.M., Frykholm B.C., Bennett M., and Tschudy D.P. Prevention of acute porphyric attacks by intravenous haematin. Lancet 2 (1978) 492-494
18. Gross U., Puy H., Meissauer U., et al. A molecular, enzymatic and clinical study in a family with hereditary coproporphyria. J Inherit Metab Dis 25 (2002) 279-286
19. Doss M.O., Stauch T., Gross U., et al. The third case of Doss porphyria (delta-amino-levulinic acid dehydratase deficiency) in Germany. J Inherit Metab Dis 27 (2004) 529-536
20. Pierach C.A. Hematin therapy for the porphyric attack. Semin Liver Dis 2 (1982) 125-131
21. Pierach C.A., Bossenmaier I., Cardinal R., Weimer M., and Watson C.J. Hematin therapy in porphyric attacks. Klin Wochenschr 58 (1980) 829-832
22. Kostrzewska E., Gregor A., and Tarczynska-Nosal S. Heme arginate (Normosang) in the treatment of attacks of acute hepatic porphyrias. Mater Med Pol 23 (1991) 259-262
23. Elder G.H., and Hift R.J. Treatment of acute porphyria. Hosp Med 62 (2001) 422-425
24. Deacon A.C., and Peters T.J. Identification of acute porphyria: evaluation of a commercial screening test for urinary porphobilinogen. Ann Clin Biochem 35 Pt 6 (1998) 726-732
25. Green D., Reynolds N., Klein J., Kohl H., and Ts'ao C.H. The inactivation of hemostatic factors by hematin. J Lab Clin Med 102 (1983) 361-369
26. Green D., Furby F.H., and Berndt M.C. The interaction of the factor VIII/von Willebrand factor complex with hematin. Thromb Haemost 56 (1986) 277-282
27. Goetsch C.A., and Bissell D.M. Instability of hematin used in the treatment of acute hepatic porphyria. N Engl J Med 315 (1986) 235-238
28. Bonkovsky H.L., Healey J.F., Lourie A.N., and Gerron G.G. Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools. Am J Gastroenterol 86 (1991) 1050-1056
29. Anderson K.E., Bonkovsky H.L., Bloomer J.R., and Shedlofsky S.I. Reconstitution of hematin for intravenous infusion. Ann Intern Med 144 (2006) 537-538